Clinical Trials · NCT01581944

Gonadotropin-releasing Hormone Agonist Prior to Myomectomy

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Mt. Hope Maternity Hospital
Enrollment
68
Start date
Jan 2008
Locations
1 site, Trinidad and Tobago
Primary endpoint
Intraoperative blood loss
View Gonadorelin compound reference